Narrative Review on Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants

Yogen Singh1, Belinda Chan2, Shahab Noori3

  • 1Department of Pediatrics, Division of Neonatology, University of California-UC Davis Children's Hospital, Sacramento, CA 95817, USA.

Insights

Persistent Patent Ductus Arteriosus (PDA) in preterm infants is common and linked to serious complications. Treatment decisions should focus on hemodynamic impact, not just PDA presence or size.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • Persistent Patent Ductus Arteriosus (PDA) is common in extremely preterm infants, with incidence inversely related to gestational age.
  • PDA is associated with increased mortality and morbidities, including intraventricular hemorrhage, pulmonary issues, and necrotizing enterocolitis.
  • Clinical trials have yielded conflicting results regarding the benefits of PDA treatment.

Purpose of the Study:

  • To review echocardiographic parameters for assessing the hemodynamic significance of PDA.
  • To explore the utility of lung ultrasound as an adjunct in evaluating PDA's impact on pulmonary circulation.
  • To emphasize individualized PDA management based on hemodynamic effects.

Main Methods:

  • Comprehensive narrative review of existing literature.
  • Description of echocardiographic techniques for hemodynamic assessment.
  • Discussion of lung ultrasound for evaluating pulmonary overcirculation.

Main Results:

  • Echocardiography provides key parameters to understand PDA's hemodynamic impact.
  • Lung ultrasound offers an adjunctive method to assess PDA's effect on pulmonary circulation.
  • Individualized assessment of hemodynamic significance is crucial for effective PDA management.

Conclusions:

  • PDA management requires a nuanced approach focusing on hemodynamic consequences.
  • Echocardiography and lung ultrasound are vital tools for assessing PDA's impact.
  • Tailoring treatment to individual hemodynamic status improves patient outcomes.